RecruitingPhase 4ACTRN12605000223639

The GABA Study

Single-dose Pregabalin in Postoperative Pain Relief after Minor Gynaecological Surgery


Sponsor

Professor Michael Paech

Enrollment

90 participants

Start Date

Aug 8, 2005

Study Type

Interventional

Conditions

Summary

Women undergoing D&C surgery often experience pain afterwards between 2 and 7 on a scale of 1-10. This pain is intially due to surgical trauma but may continue because of resulting inflammation. If the ongoing cycle of inflammation is reduced pain may be less. Pregabalin is a treatment for seizure disorders. It also has pain relieving and calming properties. It can reduce local tissue inflammation and the release of pain mediators. Therefore pregabalin given preoperatively may reduce postoperative pain.


Eligibility

Sex: Females

Inclusion Criteria1

  • Undergoing minor gynaecological surgery on uterus/cervix without skin or mucosal incision, i.e. D&C +/- Hysteroscopy. ASA 1 or 2.

Exclusion Criteria1

  • Allergy to pregabalin.History of chronic pelvic pain.Receiving preoperative misoprostol.Currently taking opioids or other forms of pain relief, sedatives or anticonvulsants.Preoperative history of dizziness or severe headaches.Petient request for sedative/anxiolytic premedication.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Single-dose pregabalin 100 mg administered 1-2 hours pre-operatively, effect on postoperative pain assessed.

Single-dose pregabalin 100 mg administered 1-2 hours pre-operatively, effect on postoperative pain assessed.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000223639